If you have not received any samples at least 1 day before the start date of a round, please contact the CFB by sending an email to office@skml.nl stating "No samples received"
| Date | Scheme | Activity | |
| 27-07-2024 24:00 | Oral oncolytics 2024.2 | Deadline | |
| 01-08-2024 0:00 | BCR::ABL1 and AML Translocation Identification 2024.2 | Start date | |
| 01-08-2024 0:00 | CD34 2024.3 | Start date | |
| 01-08-2024 0:00 | Measurable Residual Disease for AML by Mol. Meth. 2024.1 | Start date | |
| 06-08-2024 24:00 | Immunity serology 2024.1 | Deadline | |
| 13-08-2024 24:00 | Allergy 2024.3 | Deadline | |
| 13-08-2024 24:00 | Biologicals 2024.2 | Deadline | |
| 14-08-2024 0:00 | Alcohols/GHB 2024.3 | Start date | |
| 14-08-2024 0:00 | Allergy 2024.4 | Start date | |
| 14-08-2024 0:00 | Analgesic drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Antibiotic drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Antiepileptic drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Antiepileptic drugs free concentration 2024.3 | Start date | |
| 14-08-2024 0:00 | Antifungal drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Antiretroviral drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Antiviral drugs 2024.2 | Start date | |
| 14-08-2024 0:00 | Benzodiazepines 2024.3 | Start date | |
| 14-08-2024 0:00 | Biologicals 2024.3 | Start date | |
| 14-08-2024 24:00 | CD34 2024.3 | Deadline | |
| 14-08-2024 0:00 | Cardiac drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Clinical Chemistry, urine qualitative 2024.3 | Start date | |
| 14-08-2024 0:00 | Collagen 2024.2 | Start date | |
| 14-08-2024 0:00 | Drugs alternating 2024.3 | Start date | |
| 14-08-2024 0:00 | Drugs of Abuse 2024.3 | Start date | |
| 14-08-2024 0:00 | Oral oncolytics 2024.3 | Start date | |
| 14-08-2024 0:00 | POCT in whole blood 2024.3 | Start date | |
| 14-08-2024 0:00 | Psychotherapeutic drugs 2024.3 | Start date | |
| 14-08-2024 0:00 | Thiopurines 2024.3 | Start date | |
| 14-08-2024 0:00 | Toxicology 2024.3 | Start date | |
| 15-08-2024 24:00 | Antifungal drugs 2024.2 | Deadline | |
| 15-08-2024 24:00 | Antiretroviral drugs 2024.2 | Deadline | |
| 15-08-2024 24:00 | BCR::ABL1 Kinase Domain Variant (Mutation) Status 2024.1 | Deadline | |
| 16-08-2024 0:00 | Lymphocyte subsets BAL 2024.1 | Start date | |
| 19-08-2024 24:00 | Acanthamoeba Extern. Mol. Quality Assessment 2024.1 | Deadline | |
| 20-08-2024 24:00 | Clinical Chemistry, urine qualitative 2024.3 | Deadline | |
| 20-08-2024 24:00 | M-protein 2024.3 | Deadline | |
| 20-08-2024 24:00 | POCT in whole blood 2024.3 | Deadline | |
| 29-08-2024 0:00 | Urine sediment (qualitative) 2024.3 | Start date | |
| 30-08-2024 24:00 | Lymphocyte subsets BAL 2024.1 | Deadline | |
| 30-08-2024 0:00 | Semen analysis 2024.3 | Start date | |
| 31-08-2024 24:00 | BCR::ABL1 and AML Translocation Identification 2024.2 | Deadline | |
| 31-08-2024 24:00 | Hormones in Saliva 2024.4 | Deadline | CAUTION: deadlines per sample, check Qbase |
| 31-08-2024 24:00 | Hormones in Serum 2024.4 | Deadline | CAUTION: deadlines per sample, check Qbase |
| 31-08-2024 24:00 | Hormones in Urine 2024.4 | Deadline | CAUTION: deadlines per sample, check Qbase |
| 31-08-2024 24:00 | Measurable Residual Disease for AML by Mol. Meth. 2024.1 | Deadline | |
| 31-08-2024 24:00 | Tumor markers 2024.4 | Deadline | CAUTION: deadlines per sample, check Qbase |
| 01-09-2024 0:00 | BCR::ABL1 Major Quantification 2024.2 | Start date | |
| 01-09-2024 0:00 | BCR::ABL1 Minor Quantification 2024.2 | Start date | |
| 01-09-2024 0:00 | Hormones in Saliva 2024.5 | Start date | CAUTION: deadlines per sample, check Qbase |
| 01-09-2024 0:00 | Hormones in Serum 2024.5 | Start date | CAUTION: deadlines per sample, check Qbase |
| 01-09-2024 0:00 | Hormones in Urine 2024.5 | Start date | CAUTION: deadlines per sample, check Qbase |
| 01-09-2024 0:00 | Lymphocytes Subsets 2024.3 | Start date | |
| 01-09-2024 0:00 | Tumor markers 2024.5 | Start date | CAUTION: deadlines per sample, check Qbase |
| 02-09-2024 0:00 | Coagulation 2024.5 | Start date | |
| 02-09-2024 0:00 | PT-INR for oral anticoagulation 2024.5 | Start date | |
| 03-09-2024 0:00 | AML molecular diagnostics 2024.1 | Start date | |
| 03-09-2024 0:00 | D-Dimer 2024.3 | Start date | |
| 04-09-2024 0:00 | Immunosuppressant microsampling 2024.2 | Start date | |
| 05-09-2024 24:00 | Antibiotic drugs 2024.3 | Deadline | |
| 05-09-2024 24:00 | Antiepileptic drugs 2024.3 | Deadline | |
| 05-09-2024 24:00 | Antiepileptic drugs free concentration 2024.3 | Deadline | |
| 05-09-2024 24:00 | Cardiac drugs 2024.3 | Deadline | |
| 06-09-2024 24:00 | Coagulation 2024.5 | Deadline | |
| 06-09-2024 24:00 | PT-INR for oral anticoagulation 2024.5 | Deadline | |
| 09-09-2024 0:00 | Pilot Cystatin C, serum 2024.3 | Start date | |
| 09-09-2024 0:00 | Pilot Cystatin C, serum 2024.4 | Start date | |
| 10-09-2024 0:00 | Blood parasites 2024.3 | Start date | |
| 10-09-2024 0:00 | Intestinal-, tissue and ecto parasites 2024.3 | Start date | |
| 10-09-2024 0:00 | Leukemia/Lymphoma typing 2024.3 | Start date | |
| 10-09-2024 0:00 | Molecular Biology various 2024.2 | Start date | |
| 10-09-2024 0:00 | Pharmacogenetics 2024.2 | Start date | |
| 10-09-2024 0:00 | Thrombophilia (genetics) 2024.2 | Start date | |
| 11-09-2024 0:00 | Diabetes 2024.1 | Start date | |
| 11-09-2024 0:00 | Erythrocyte serology basic 2024.3 | Start date | |
| 11-09-2024 0:00 | HbA1c whole blood 2024.5 | Start date | |
| 11-09-2024 0:00 | Helicobacter pylori (Ag) in feces 2024.1 | Start date | |
| 12-09-2024 24:00 | Analgesic drugs 2024.3 | Deadline | |
| 12-09-2024 24:00 | Benzodiazepines 2024.3 | Deadline | |
| 12-09-2024 24:00 | Drugs alternating 2024.3 | Deadline | |
| 12-09-2024 24:00 | HBsAg screen 2024.3 | Deadline | |
| 12-09-2024 24:00 | HCV screen 2024.3 | Deadline | |
| 12-09-2024 24:00 | HIV screen 2024.3 | Deadline | |
| 12-09-2024 24:00 | HTLV-I screen 2024.3 | Deadline | |
| 12-09-2024 24:00 | Hemocytometry 2024.5 | Deadline | |
| 12-09-2024 0:00 | Hemocytometry 2024.5 | Start date | |
| 12-09-2024 24:00 | Lues screen (TPHA) 2024.3 | Deadline | |
| 12-09-2024 24:00 | Psychotherapeutic drugs 2024.3 | Deadline | |
| 12-09-2024 24:00 | Thiopurines 2024.3 | Deadline | |
| 12-09-2024 24:00 | anti-HBc screen 2024.3 | Deadline | |
| 12-09-2024 24:00 | anti-HBs screen 2024.3 | Deadline | |
| 13-09-2024 24:00 | Collagen 2024.2 | Deadline | |
| 13-09-2024 24:00 | HbA1c whole blood 2024.5 | Deadline | |
| 14-09-2024 24:00 | Lymphocytes Subsets 2024.3 | Deadline | |
| 14-09-2024 24:00 | Oral oncolytics 2024.3 | Deadline | |
| 16-09-2024 24:00 | D-Dimer 2024.3 | Deadline | |
| 17-09-2024 0:00 | ANCA-GBM 2024.2 | Start date | |
| 17-09-2024 0:00 | Antibodies against skin 2024.1 | Start date | |
| 17-09-2024 0:00 | Fetomaternal transfusion 2024.2 | Start date | |
| 17-09-2024 0:00 | Helminth External Mol. Quality Assessment 2024.1 | Start date | |
| 17-09-2024 0:00 | Mycobacteriology 2024.1 | Start date | |
| 17-09-2024 0:00 | PNH diagnostics 2024.3 | Start date | |
| 18-09-2024 0:00 | Blood pigments in cerebrospinal fluid 2024.2 | Start date | |
| 18-09-2024 0:00 | Liquor protein 2024.2 | Start date | |
| 19-09-2024 24:00 | Alcohols/GHB 2024.3 | Deadline | |
| 19-09-2024 24:00 | Drugs of Abuse 2024.3 | Deadline | |
| 19-09-2024 24:00 | Toxicology 2024.3 | Deadline | |
| 23-09-2024 24:00 | AML molecular diagnostics 2024.1 | Deadline | |
| 23-09-2024 24:00 | Erythrocyte serology basic 2024.3 | Deadline | |
| 23-09-2024 24:00 | Leukemia/Lymphoma typing 2024.3 | Deadline | |
| 24-09-2024 24:00 | Fetomaternal transfusion 2024.2 | Deadline | |
| 24-09-2024 0:00 | Mycology 2024.2 | Start date | |
| 25-09-2024 0:00 | Antibiotic drugs 2 2024.2 | Start date | |
| 25-09-2024 0:00 | Antituberculosis drugs 2024.2 | Start date | |
| 25-09-2024 0:00 | Bordetella serology 2024.1 | Start date | |
| 25-09-2024 24:00 | Semen analysis 2024.3 | Deadline |
